Clinical Trial Update: UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating epacadostat with intralesional SD101 and radiotherapy in lymphoma and advanced solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Epacadostat (epacadostat)
• SD101 (SD101)

Snippet

Sponsor: University of California, Davis | Conditions: Advanced Solid Tumors, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-21